This study assessed the relationships between body mass index (BMI) and different outcomes after adult cardiac surgery by linking detailed preoperative comorbidity data with the long-term mortality and morbidity outcomes of 2131 consecutive patients who had elective cardiac surgery at a major cardiac surgical hospital in Western Australia. Patients with a high BMI had more comorbidities and were more likely to have had coronary artery bypass grafting than valve surgery. A total of 143 patients (6.7%) died during a median follow-up period of 30 months. The major causes of death were congestive heart failure (25.9%), myocardial infarction (14.7%), infection (23.8%) and cancer (13.9%). BMI had no association with long-term mortality, after adjusting for important confounders including the Charlson Comorbidity Index. BMI had a relatively linear relationship with the risk of new-onset atrial fibrillation (odds ratio 1.05 per point increment, 95% confidence interval 1.03 to 1.05) and venous thromboembolism (odds ratio 1.20, 95% confidence interval 1.14 to 1.26). BMI was the second most important predictor after age and accounted for 22% of the variability in the risk of atrial fibrillation. BMI had an inverse relationship with the risk of requiring allogeneic blood transfusion, postoperative intraaortic balloon pump, or surgical re-exploration. In summary, BMI had differential associations with different short-and long-term outcomes after elective adult cardiac surgery. After adjusting for important confounders including the presence of cancers, we did not observe any 'obesity paradox' and patients with a high BMI were not associated with an increased probability of long-term survival.
Survival after cardiac surgery has substantially improved in the past two decades 1 . However, complications such as atrial fibrillation, haemorrhage requiring transfusion, infection and cardiac failure requiring intra-aortic balloon pump remain common post cardiac surgery, especially in high-risk patients 1, 2 . In addition to the attributable effect on patient mortality and morbidity, complications after cardiac surgery also increase the overall healthcare cost and account for over 20% of the total expenditure on cardiac surgery 3 . It has been estimated that the healthcare cost for every adverse event that occurs after cardiac surgery was well over $5000 in Australia 3 .
The latest estimates show that approximately 34% of adults and 15 to 20% of children and adolescents in the US and 17 to 18% of adults in Australia are obese 4 . Unfortunately, the obesity epidemic continues to grow in many developed countries despite numerous public health initiatives 5 . Obesity is associated with many medical illnesses including coronary artery disease, sleep apnoea, diabetes mellitus, gastrointestinal reflux and hypertension 6 . As such, it is expected that obese cardiac surgical patients will become more prevalent in the future 7 . It is intuitive to assume that patients with a body mass index (BMI) outside the normal range would experience poorer health outcomes than individuals who have a normal BMI 8 . However, this common perception may not be applicable to cardiac surgical patients and some investigators have suggested that a high BMI may indeed be protective 7, [9] [10] [11] [12] . Whether an 'obesity paradox' really exists in cardiac surgery remains highly controversial 10, 13 .
The conflicting results of the many existing reports on the relationship between BMI and outcome after cardiac surgery primarily stem from a lack of detailed preoperative comorbidity data, in particular data on pre-existing cancers, to control for confounding, arbitrary grouping of patients with different BMI as overweight, obese or morbidly obese 14 and a lack of data on long-term complications after hospital discharge. Furthermore, very few reports have considered a non-linear relationship between BMI and outcomes after cardiac surgery 9, 15 . In this study, we aimed to overcome some of these limitations by including detailed comorbidity data, including the Charlson Comorbidity Index, prior to surgery to reduce residual confounding, modelling BMI as a continuous non-linear predictor, and also assessing the associations between BMI and different long-term outcomes after cardiac surgery, including new-onset atrial fibrillation, venous thromboembolism, sternal wound infection and stroke.
METHODS

Patient characteristics and setting
After obtaining the Mount Hospital (EC69.2), Western Australian Department of Health (2012/25), and University of Notre Dame (012030F) Ethics Committees' approval, the cardiac anaesthesia database of the Mount Hospital was linked to the Western Australian Death Registry and Department of Health Hospital Morbidity Data System using probabilistic matching 16 . A single data custodian has been collecting and checking cardiac anaesthesia perioperative data of all cardiac surgical patients since the inception of the cardiac anaesthesia database of Mount Hospital in 2008 and missing data was found to be < 0.5%. The proportions of invalid (false positives) and missed links (false negatives) of the techniques used by the Western Australian Data linkage Unit had been evaluated and both false positives and false negatives were estimated to be 0.11% 17 . Recently, the techniques used by the Western Australian Data linkage Unit to obtain linkage of health data across different jurisdictions had also been applied to other states in Australia and was found to be capable of providing high quality data for research purposes 18 .
Mount Hospital is the largest tertiary cardiothoracic private hospital in Western Australia and has six cardiothoracic surgeons performing about 500 to 600 open-heart surgical operations per year. The Western Australian Health Hospital Morbidity Data System collection commenced in 1970 and includes all inpatient episodes for defined admitted patients to public, private and freestanding day hospitals in Western Australia. This database has demographic information together with up to 21 diagnostic codes and 11 procedural codes, recorded at the time of hospital discharge using the International Classification of Diseases (ICD 10-AM). The quality of the hospital administrative data is regularly validated by 21 different quality checks and periodic audits. The Health Hospital Morbidity Data System provided detailed information on morbidity up to five years before the index admission for cardiac surgery to calculate the Charlson Comorbidity Index 19 and also long-term complications such as new-onset atrial fibrillation, venous thromboembolism, stroke and deep sternal wound infection after cardiac surgery. The syntax used to retrieve the Charlson Comorbidity Index and complications after surgery is described in the Appendix in the online version of this paper. A relatively long, five-year 'look back' period was used in this study to capture all existing comorbidities of each patient and we did not assign a comorbidity to a patient if that condition was diagnosed during the hospitalisation for cardiac surgery, to avoid misclassification between premorbid conditions before surgery and complications after surgery.
The death registry, together with post mortem and coroners' reports when available, provided the date and causes of death for those who died during the follow-up period of this study. The censor date for survival and long-term complications was 31 August 2012 and the median follow-up time for the whole cohort was 30 months after surgery (interquartile range 17 to 43months).
Sample size estimation and outcomes of interest
Assuming about 600 adult cardiac surgical patients were overweight or obese, relative to 1200 patients who were normal or underweight and a P value <0.05 was taken as significant, a total sample size of 2000 patients would have >80% power to detect a relative risk of >1.5 between different BMI subgroups on risk of long-term complications or mortality if the incidence of these events was >3%. This sample size would have similar power to detect a relative risk of 1.09 per BMI increment when BMI was modelled as a continuous predictor. The outcomes or complications of interest of this study included mortality, new-onset atrial fibrillation, stroke, surgical re-exploration for bleeding or cardiac tamponade, sternal wound infection requiring antibiotics or surgical debridement, acute kidney injury requiring dialysis, allogeneic blood transfusion, massive transfusion (10 units of packed red blood cells during the perioperative period), postoperative heart failure or cardiogenic shock requiring intra-aortic balloon pump, pneumonia requiring antibiotics and venous thromboembolism.
Statistical analysis
First, we explored the differences in preoperative, intraoperative and postoperative characteristics between patients in different major subgroups of BMI (a low or normal BMI ≤24.9 kg/m 2 ; overweight BMI from 25 to 30 kg/m 2 ; and obesity BMI >30 kg/m 2 ) 20 . In this exploratory univariate analysis, categorical and continuous variables with skewed distributions were analysed by chi-square and Kruskal-Wallis oneway analysis of variance tests, respectively.
Second, multivariate logistic regression was used to assess the relationships between BMI and different long-term complications after surgery, allowing all continuous variables non-linearity by using a three-knot restricted cubic spline function 21, 22 . A restricted cubic spline function is similar to a polynomial function and will allow a continuous pre-dictor to displace a multimodal non-linear relation to the categorical outcome in a logistic regression model. The covariates analysed in the multivariate model were chosen according to their plausible clinical effect on long term outcomes after cardiac surgery and they included age, gender, Euro-SCORE 23 , Charlson Comorbidity Index and type of cardiac surgery. In this study, EuroSCORE was used as a composite covariate to capture the urgency of surgery, ejection fraction and also other prognostic factors to minimise residual confounding and, at the same time, reduce the risk of undermining the power of the statistical analysis. The relative contribution of BMI relative to other predictors was assessed using the chi-square statistic minus the degrees of freedom 21 . Interaction terms were not included in the multivariate regression model because we planned to limit the analysis to a maximum of one predictor per 10 to 12 outcomes.
Third, as a sensitivity analysis, the association between survival and BMI was also assessed by a Cox regression model, using the same covariates as in the logistic regression model and a restricted cubic spline function to allow non-linearity for all continuous predictors. All analyses were perfor- 
RESUlTS
Of the 2151 consecutive patients who had cardiac surgery in the study period, linkage of their premorbid health conditions and postoperative survival and long-term outcome data was successful in 2131 patients (99.1%) ( Figure 1 ). The mean BMI of the whole cohort was 28.2 (median 27.8; standard deviation 4.9; range 14 to 67; and interquartile range 25 to 31) and the distribution of BMI is described in Figure 2 .
Difference in preoperative characteristics between patients in different subgroups of BMI
Patients with a BMI >30 were younger, more likely to have had coronary artery bypass grafting than valve surgery, and had more medical comorbidities including diabetes mellitus (19%) and sleep apnoea (8.1%), but they also had a lower Euro-SCORE compared to patients who had a lower BMI (Table 1 ). 
Difference in intraoperative and postoperative outcomes between patients in different subgroups of BMI
Patients with a BMI>30 had less intraoperative bleeding, perioperative transfusion requirements and risk of surgical re-exploration for bleeding or cardiac tamponade than patients who had a lower BMI. However, patients with a high BMI had a significantly higher incidence of newonset atrial fibrillation and venous thromboembolism than the subgroups of patients with a lower BMI ( Table 1) .
BMI as a continuous predictor for in-hospital and longterm outcomes after cardiac surgery
A total of 143 patients (6.6%) died on or before the date of censor and the main causes of death were congestive heart failure (25.9%), acute myocardial infarction (14.7%), infection (23.8%), cancer (13.9%), stroke (8.4%) and venous thromboembolism (2.8%) ( Figure 1 1.04; P=0.873), stroke, pneumonia, sternal wound infection and acute kidney injury requiring dialysis were not significantly associated with BMI after adjusting for age, gender, Charlson Comorbidity Index, EuroSCORE and type of surgery (Table 2) . However, a high BMI was associated with a higher risk of new-onset atrial fibrillation (OR 1.05 per BMI point increment, 95% CI 1.03 to 1.05) and venous thromboembolism (OR 1.20 per BMI point increment, 95% CI 1.14 to 1.26) in a relatively linear fashion (Figures 3 and 4) , after adjusting for important confounders. BMI was more important than EuroSCORE and Charlson Comorbidity Index and explained about 22 and 69% of the variability in new-onset atrial fibrillation and venous thromboembolism, respectively ( Figures  5 and 6 ).
Conversely, a lower BMI was a risk factor for requiring allogeneic blood transfusion (OR 0.9 per BMI point increment, 95% CI 0.93 to 0.97) and surgical re-exploration for bleeding or cardiac tamponade (OR 0.93 per BMI point increment, 95% CI 0.89 to 0.98) ( Table 2 ), in an inverse linear fashion (Figure 7) . BMI was the third most important factor in explaining the variability in the risk of requiring allogeneic transfusion or surgical re-exploration ( Figure 8 ).
In the sensitivity analysis, BMI remained not related to the long-term survival time (hazard ratio 1.01, 95% CI 0.97 to 1.04; P=0.721), after adjusting for age, gender, Charlson Comorbidity Index, EuroSCORE and type of surgery. Age (OR 1.06 per year increment, 95% CI 1.03 to 1.08), EuroSCORE (OR 1.09 per point increment, 95% CI 1.01 to 1.17) and Charlson Comorbidity Index (OR 1.27 per point increment, 95% CI 1.16 to 1.38) were the only significant predictors of long-term mortality ( Table 2) .
DISCUSSION
Our results show that BMI had complex and different associations with different outcomes after elective adult cardiac surgery. After adjusting for important confounders, including the presence of cancers and other coexisting diseases, we did not observe any obesity paradox and patients with a high BMI were not associated with an increased probability of long-term survival compared to patients with a low BMI. A high BMI was associated with an increased risk of long-term, newonset atrial fibrillation and venous thromboembolism after surgery, but a reduced risk of requiring allogeneic blood transfusion and surgical reexploration immediately after surgery. These findings have some clinical significance and require careful consideration.
First, obesity or a high BMI has been suggested to be protective in terms of survival after cardiac surgery 11 -often called obesity paradox. In this study, we did not observe this obesity paradox. Patients with a high BMI were not associated with a longer survival time after cardiac surgery compared to those with a lower BMI, after adjusting for important confounders including the presence of cancers. The difference in this result between our study and those that reported an obesity paradox may be due to the fact that detailed comorbidity data, in particular presence of cancers, was not adjusted for in previous studies. We noted that cancers accounted for about 13.9% of all deaths within a median period of 30 months after surgery and could have accounted for the negative association between a lower BMI and mortality after pre-existing cancers had been adjusted for.
Second, atrial fibrillation after cardiac surgery is very common and is associated with significant attributable mortality and morbidities 24, 25 . Our study has shown that BMI has a relatively linear dose-related relationship with the risk of new-onset atrial fibrillation over a median period of 30 months after cardiac surgery, consistent with previous reports on the relationship between obesity and risk of new-onset atrial fibrillation [26] [27] [28] [29] . The mechanism behind the relationship between a high BMI and atrial fibrillation may be related to the interrelated associations between diastolic dysfunction, enlarged left atrium, hypertension, sleep apnoea and obesity 27, 30, 31 . As such, BMI should be considered as a risk factor for new-onset atrial fibrillation after cardiac surgery and a potential confounder or target for research related to prevention of long-term atrial fibrillation after cardiac surgery. Whether using an extended period of anti-arrhythmic therapy for patients with a high BMI can reduce their risk of new-onset atrial fibrillation and its associated complications remains, however, uncertain. Third, venous thromboembolism is a major cause of mortality and morbidity in hospitalised patients. Various abnormalities of haemostasis, including increased platelet aggregability, circulating mircoparticles and reduced fibrinolysis, have been reported in obesity and are associated with an increased risk of venous thromboembolism 32 . Furthermore, there is always a possibility that the elevated risk of venous thromboembolism found in association with increasing BMI might be, at least in part, due to a relative under-dosing of prophylactic anticoagulation. Our results have confirmed that a high BMI is an important risk factor for venous thromboembolism including fatal pulmonary embolism (2.8%) 33, 34 . Although it is intuitive to assume that the use of an extended period of venous thromboembolism prophylaxis after cardiac surgery may reduce the risk of venous thromboembolism for patients with a high BMI 35 , the overall risk to benefit balance or cost-effectiveness of such a strategy remains scientifically unproven until confirmed by an adequately powered randomised controlled trial. Given obesity is associated with an increased risk of thromboembolism, an inverse relationship between bleeding, transfusion requirements or surgical re-exploration and BMI is, perhaps, not surprising. Similar findings have also been reported in another study 36 . Furthermore, a higher incidence of perioperative hypothermia 37 and a greater degree of haemodilution during cardiopulmonary bypass may also contribute to an increased risk of bleeding, requiring allogeneic blood transfusion in patients with a low BMI.
The final consideration is the strengths and limitations of this study. In the first instance, we modelled BMI as a continuous non-linear variable in our multivariable analysis. This would have allowed a U-shape or J-shape relationship between BMI and the different outcomes to be observed 21, 22 . We also had causes of death after hospital discharge, which has not been well reported in previous studies. Second, patients with a low BMI are frequently associated with many medical conditions, including cancers, which may explain the apparent obesity paradox of better long-term survival in patients with a high BMI 11, 38 . Our study showed that Charlson Comorbidity Index was, indeed, an important predictor of many long-term outcomes after cardiac surgery, including mortality, stroke, acute kidney injury requiring dialysis, allogeneic blood transfusion, massive transfusion, heart failure requiring intra-aortic balloon pump, pneumonia and venous thromboembolism. Hence, comorbidities associated with both high and low BMI can certainly confound the relationships between BMI and outcomes after cardiac surgery and should be adjusted for in similar studies in the future. However, this study is limited by its relatively small sample size and as such, the results are imprecise with wide confidence intervals and we cannot exclude a type 2 error in the negative associations between BMI and some relatively rare outcomes, such as sternal wound infection (1.1%) and acute kidney failure requiring dialysis (2.3%), especially if the relative risks associated with these outcomes and BMI were small (e.g. OR <1.1 per BMI increment). Furthermore, we did not use any interaction terms in the modelling process and as such, we cannot possibly exclude synergistic effect (in contrast to additive effect) between BMI and other covariates on the outcomes of the patients. We also did not have data on hip to waist ratio or any measures of abdominal adiposity, and we could not assess whether these parameters were more important predictors of outcomes after cardiac surgery. Finally, this was a single centre study and hence, our results may not be generalisable to other cardiac surgical centres.
CONClUSIONS
In summary, BMI has complex and differential associations with different outcomes after elective adult cardiac surgery. A high BMI was not associated with a better chance of long-term survival after adjusting for important confounders including comorbidities such as cancers. A high BMI a) was associated with an increased risk of longterm new-onset atrial fibrillation and venous thromboembolism after surgery, but a reduced risk of requiring allogeneic blood transfusion and surgical re-exploration in the immediate postoperative period. Whether an extended period of anti-arrhythmic (e.g. low-dose amiodarone) and thromboprophylaxis therapy can improve patient-centred outcomes for cardiac surgical patients with a high BMI remains uncertain, but this merits further investigation by a randomised controlled trial.
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